Cargando…
Le nirmatrelvir-ritonavir (Paxlovid®), un traitement contre la Covid-19
The nirmatrelvir-ritonavir (Paxlovid®) is a treatment against Covid-19 available in pharmacies since February 4, 2022. Administered orally, it is intended only for people at very high risk of contracting one or more severe forms of the disease.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304942/ https://www.ncbi.nlm.nih.gov/pubmed/35891982 http://dx.doi.org/10.1016/j.actpha.2022.05.002 |